Barclays’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
268,467
+27,124
| +11% | +$204K | ﹤0.01% | 2221 |
|
|
2025
Q1 | $1.83M | Sell |
241,343
-3,888
| -2% | -$29.4K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $2.99M | Sell |
245,231
-3,383
| -1% | -$41.2K | ﹤0.01% | 1955 |
|
|
2024
Q3 | $4.16M | Buy |
248,614
+51,300
| +26% | +$859K | ﹤0.01% | 1662 |
|
|
2024
Q2 | $3.44M | Buy |
197,314
+157,122
| +391% | +$2.74M | ﹤0.01% | 1363 |
|
|
2024
Q1 | $685K | Sell |
40,192
-45,032
| -53% | -$767K | ﹤0.01% | 2648 |
|
|
2023
Q4 | $867K | Buy |
85,224
+31,831
| +60% | +$324K | ﹤0.01% | 2696 |
|
|
2023
Q3 | $483K | Buy |
53,393
+31,650
| +146% | +$286K | ﹤0.01% | 2574 |
|
|
2023
Q2 | $232K | Sell |
21,743
-6,570
| -23% | -$70.1K | ﹤0.01% | 3014 |
|
|
2023
Q1 | $291K | Buy |
28,313
+6,817
| +32% | +$70.1K | ﹤0.01% | 2952 |
|
|
2022
Q4 | $227K | Buy |
21,496
+12,502
| +139% | +$132K | ﹤0.01% | 3026 |
|
|
2022
Q3 | $116K | Buy |
8,994
+1,731
| +24% | +$22.3K | ﹤0.01% | 3357 |
|
|
2022
Q2 | $93K | Sell |
7,263
-65
| -0.9% | -$832 | ﹤0.01% | 3488 |
|
|
2022
Q1 | $77K | Buy |
+7,328
| New | +$77K | ﹤0.01% | 3796 |
|